Evidence map›Paper›PMID 29995108›Full record

ArticleBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2018

Strontium ranelate inhibits wear particle-induced aseptic loosening in mice.

Tianxiang Geng, Shouxuan Sun, Haochen Yu, Haohui Guo, Mengxue Zheng, Shuai Zhang, Xi Chen, Qunhua Jin

Open access · goldAbstract read
In one paragraph

Article in Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. The Effects of Biomaterial Implant Wear Debris on Osteoblasts.Frontiers in cell and developmental biology · 2020
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tianxiang GengNingxia Medical University, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Shouxuan SunDepartment of Orthopedic Surgery, General Hospital of Ningxia Medical University, Ningxia Medical University, Yinchuan, Ningxia, China.
Haochen YuNingxia Medical University, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Haohui GuoDepartment of Orthopedic Surgery, General Hospital of Ningxia Medical University, Ningxia Medical University, Yinchuan, Ningxia, China.
Mengxue ZhengNingxia Medical University, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Shuai ZhangDepartment of Orthopedic Surgery, General Hospital of Ningxia Medical University, Ningxia Medical University, Yinchuan, Ningxia, China.
Xi ChenNingxia Medical University, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Qunhua JinDepartment of Orthopedic Surgery, General Hospital of Ningxia Medical University, Ningxia Medical University, Yinchuan, Ningxia, China.
Ningxia Medical University · CNNingxia Medical University General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The imbalance between bone formation and osteolysis plays a key role in the pathogenesis of aseptic loosening. Strontium ranelate (SR) can promote bone formation and inhibit osteolysis. The aim of this study was to explore the role and mechanism of SR in aseptic loosening induced by wear particles. Twenty wild-type (WT) female C57BL/6j mice and 20 sclerostin-/- female C57BL/6j mice were used in this study. Mice were randomly divided into four groups: WT control group, WT SR group, knockout (KO) control group, and KO SR group. We found that SR enhanced the secretion of osteocalcin (0.72±0.007 in WT control group, 0.98±0.010 in WT SR group, P=0.000), Runx2 (0.34±0.005 in WT control group, 0.47±0.010 in WT SR group, P=0.000), β-catenin (1.04±0.05 in WT control group, 1.22±0.02 in WT SR group, P=0.000), and osteoprotegerin (OPG) (0.59±0.03 in WT control group, 0.90±0.02 in WT SR group, P=0.000). SR significantly decreased the level of receptor activator for nuclear factor-κB ligand (RANKL) (1.78±0.08 in WT control group, 1.37±0.06 in WT SR group, P=0.000) and improved the protein ratio of OPG/RANKL, but these effects were not observed in sclerostin-/- mice. Our findings demonstrated that SR enhanced bone formation and inhibited bone resorption in a wear particle-mediated osteolysis model in wild-type mice, and this effect relied mainly on the down-regulation of sclerostin levels to ameliorate the inhibition of the canonical Wnt pathway.

Indexed as

Artificial LimbsProsthesis ImplantationAnimalsBiomechanical PhenomenaBlotting, WesternBone ResorptionEnzyme-Linked Immunosorbent AssayFemaleLower ExtremityMiceMice, Inbred C57BLOsteolysisThiophenesstrontium ranelateThiophenes

Identifiers

PMID29995108
PMCPMC6050946
OpenAlexW2883876931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.